Diagnostic Biomarker Found for Esophageal Squamous Cell Carcinoma
|
By LabMedica International staff writers Posted on 22 Jan 2020 |

Image: Histological immunostaining showing expression of leucine‐rich repeat‐containing G protein–coupled receptor 6 (LGR6) in esophageal squamous cell carcinoma (ESCC) and normal esophageal tissues (NT) (Photo courtesy of Fujian Medical University).
Esophageal cancer is one of the most common malignant tumors in the world, and its incidence ranks seventh among those of all malignant tumors. Esophageal cancer can be divided into two pathological types: squamous cell carcinoma (SCC) and adenocarcinoma.
Leucine‐rich repeat‐containing G protein–coupled receptor (LGR) plays a pivotal role in adult stem cells, which are markers of various types of adult stem cells in the skin, nails, and a group of basal and intraluminal progenitors that induce luminal tumorigenesis. LGR6 can promote the self‐renewal and progression of non–small‐cell lung cancer and has strong carcinogenic potential.
Scientists at the Fujian Medical University Union Hospital (Fuzhou, China) collected during surgical resection of esophageal cancer, 102 Esophageal Squamous Cell Carcinoma (ESCC) samples and their corresponding non‐tumor esophageal tissues. Tissues were immediately frozen in liquid nitrogen and stored in a −80 °C freezer or fixed in 10% formalin for paraffin embedding.
Total RNA was extracted from frozen tissue and 1 mg of RNA was reverse transcribed for first complementary DNA strand synthesis using a miScript Reverse Transcription Kit (Qiagen, Hilden Germany). Real‐time quantitative polymerase chain reaction (PCR) was performed using a SYBR Premix EX Taq Kit (TakaraBio, Shiga, Japan). The relative mRNA expression of LGR6 was detected with the 2(-Delta Delta C(T)) method using specific primers and its expression level was normalized to that of endogenous β‐actin. Other techniques used by the investigators included Western Blots Analysis and immunohistochemistry (IHC).
The scientists reported that the expression of LGR6 in ESCC tissues was significantly higher than that in normal tissues and was negatively correlated with the differentiation degree of ESCC and the prognosis of the patients but not closely correlated with the Classification of Malignant Tumors (TNM) stage of ESCC. Protein‐protein interaction (PPI) networks showed that LGR6 had a close interaction with R-spondin-1 (RSPO1), RSPO2, RSPO3, and RSPO4. Kyoto encyclopedia of genes and genomes (KEGG) pathway analysis showed that LGR6 activated the Wnt/β‐catenin signaling pathway by binding with RSPO ligands to promote the progression of ESCC.
The authors concluded that the study confirmed for the first time that LGR6 is highly expressed in ESCC tissues and that increased expression of LGR6 is associated with a poor prognosis of ESCC patients. These findings provide a basis for the potential application of LGR6 as a biomarker for early diagnosis and as a target gene for early therapeutic intervention. The study was published on January 9, 2020 in the Journal of Clinical Laboratory Analysis.
Related Links:
Fujian Medical University Union Hospital
Qiagen
TakaraBio
Leucine‐rich repeat‐containing G protein–coupled receptor (LGR) plays a pivotal role in adult stem cells, which are markers of various types of adult stem cells in the skin, nails, and a group of basal and intraluminal progenitors that induce luminal tumorigenesis. LGR6 can promote the self‐renewal and progression of non–small‐cell lung cancer and has strong carcinogenic potential.
Scientists at the Fujian Medical University Union Hospital (Fuzhou, China) collected during surgical resection of esophageal cancer, 102 Esophageal Squamous Cell Carcinoma (ESCC) samples and their corresponding non‐tumor esophageal tissues. Tissues were immediately frozen in liquid nitrogen and stored in a −80 °C freezer or fixed in 10% formalin for paraffin embedding.
Total RNA was extracted from frozen tissue and 1 mg of RNA was reverse transcribed for first complementary DNA strand synthesis using a miScript Reverse Transcription Kit (Qiagen, Hilden Germany). Real‐time quantitative polymerase chain reaction (PCR) was performed using a SYBR Premix EX Taq Kit (TakaraBio, Shiga, Japan). The relative mRNA expression of LGR6 was detected with the 2(-Delta Delta C(T)) method using specific primers and its expression level was normalized to that of endogenous β‐actin. Other techniques used by the investigators included Western Blots Analysis and immunohistochemistry (IHC).
The scientists reported that the expression of LGR6 in ESCC tissues was significantly higher than that in normal tissues and was negatively correlated with the differentiation degree of ESCC and the prognosis of the patients but not closely correlated with the Classification of Malignant Tumors (TNM) stage of ESCC. Protein‐protein interaction (PPI) networks showed that LGR6 had a close interaction with R-spondin-1 (RSPO1), RSPO2, RSPO3, and RSPO4. Kyoto encyclopedia of genes and genomes (KEGG) pathway analysis showed that LGR6 activated the Wnt/β‐catenin signaling pathway by binding with RSPO ligands to promote the progression of ESCC.
The authors concluded that the study confirmed for the first time that LGR6 is highly expressed in ESCC tissues and that increased expression of LGR6 is associated with a poor prognosis of ESCC patients. These findings provide a basis for the potential application of LGR6 as a biomarker for early diagnosis and as a target gene for early therapeutic intervention. The study was published on January 9, 2020 in the Journal of Clinical Laboratory Analysis.
Related Links:
Fujian Medical University Union Hospital
Qiagen
TakaraBio
Latest Pathology News
- Researchers Evaluate Automated Tissue Analysis Across Four Cancer Types
- AI Prostate Cancer Test Added to NCCN Guidelines for Post-Surgery Recurrence
- New Training Approach Helps AI Distinguish Neighboring Cells in Tissue
- Breakthrough-Designated Cytology Test Supports Oral Cancer Risk Assessment
- Review Highlights Progress and Validation Needs for AI in Digital Pathology
- Roche Launches Automated Test to Support Mesothelioma Differential Diagnosis
- AI Pathology Approach Closely Aligns With Breast Cancer Genomic Risk Classification
- Digital Pathology Test Stratifies Recurrence Risk in Early Breast Cancer
- AI Pathology Tool Predicts DNA Repair Deficiency in High-Grade Serous Ovarian Cancer
- AI Tissue Analysis May Help Identify Missed Precancerous Colon Polyps
- AI Pre-Screening Helps Identify Lung Cancer Cases for Additional Biomarker Testing
- AI Pathology Platform Targets Workflow Delays and Molecular Test Failures
- Updated Digital Pathology Platform Expands AI Integration for Cancer Diagnosis
- Molecular Testing Refines Barrett’s Esophagus Progression Risk Beyond Biopsy Findings
- AI Histopathology Tool Distinguishes Ewing Sarcoma for Diagnosis
- Rapid Mass Spectrometry Test May Aid Glioma Margin Decisions
Channels
Clinical Chemistry
view channelAI and Nanotechnology Enable Five-Minute Urine Drug Screening
Rapid screening for illicit drugs remains challenging when testing must be performed at the point of care. Laboratory methods provide accurate results but require sample preparation and specialized equipment,... Read more
Study Questions Uniform Stool-Test Cutoff Across Age Groups
Colorectal cancer remains a major clinical challenge, ranking as the fourth most common cancer and the second-leading cause of cancer death in the U.K. Early-onset colorectal cancer, defined as diagnosis... Read moreMolecular Diagnostics
view channel
Blood RNA Patterns Linked to CAR T-Cell Response and Survival in Lymphoma
Anti-CD19 chimeric antigen receptor (CAR) T-cell therapy, which involves engineering a patient’s own immune cells to recognize and attack cancer cells, has transformed treatment for large B-cell lymphoma,... Read moreGenome Sequencing Provides Clues to Unexplained Recurrent Miscarriages
Recurrent pregnancy loss, defined as two or more miscarriages, affects about 5% of couples. In many cases, routine evaluation does not identify a cause, particularly when pregnancies have a normal chromosome... Read moreHematology
view channel
Werfen Gains FDA Clearance for ROTEM sigma Cartridge Use in Trauma
Traumatic injuries account for approximately 10% of deaths worldwide, with uncontrolled bleeding remaining a leading cause of potentially preventable trauma-related death. Trauma-induced coagulopathy further... Read more
Serial Blood Samples Reveal Leukemia’s Evolution Decades Before Diagnosis
Acute myeloid leukemia (AML) is an aggressive blood cancer affecting approximately 2,700 people in the U.K. annually, with only about one in six patients surviving five years after diagnosis.... Read moreImmunology
view channel
Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice
Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more
Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis
Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more
Antibody Testing Informs Melioidosis Diagnosis and Surveillance in Emerging Regions
Melioidosis is a serious and sometimes fatal infection caused by the soil- and water-dwelling bacterium Burkholderia pseudomallei. People and animals can contract the disease through exposure to contaminated... Read moreMicrobiology
view channel
WHO Survey Reveals Gaps in Antimicrobial Resistance Testing and Response
Antimicrobial resistance (AMR) remains a major challenge for health systems, limiting effective treatment options for drug-resistant infections. These infections caused more than 1 million deaths and contributed... Read more
Direct-From-Specimen Pneumonia Test Detects Pathogens and Resistance in Hours
Pneumonia is a leading cause of sepsis and is associated with high mortality. Conventional culture-based pathogen identification and antimicrobial susceptibility testing can take two to four days, delaying... Read moreTechnology
view channel
Experimental Blood Test Detects Markers of Three Cancers and Alzheimer’s Disease
Colorectal cancer, glioblastoma, pancreatic cancer, and Alzheimer’s disease are serious conditions in which earlier detection may improve clinical outcomes. Blood-based testing could help identify dis... Read more
New qPCR Master Mixes Offer Broad Compatibility for Routine Research
Quantitative PCR (qPCR) workflows require consistent reagent performance across instruments and assay formats. Laboratories must also manage costs without changing established protocols.... Read moreIndustry
view channel
Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil
Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more







